Interestingly, we found that knocking down NEK1 or treating ccRCC cells with the NEK1 inhibitor increased the acetylation level of ETS1‐K245, but overexpressing NEK1 WT decreased the level of ETS1‐K245ac (Figure 6H). The gene discussed is NEK1; the disease is nonpapillary renal cell carcinoma.